OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers
Phase 4
Completed
- Conditions
- Dry Eye
- Interventions
- Drug: OC-01 (varenicline 0.6mg/ml) Nasal SprayDrug: Placebo (vehicle) nasal spray
- First Posted Date
- 2021-12-17
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- Center for Ophthalmic and Vision Research, LLC
- Target Recruit Count
- 75
- Registration Number
- NCT05161208
- Locations
- 🇺🇸
Center for Ophthalmic and Vision Recearch, New York, New York, United States
CEQUA for Sjogren's Syndrome Dry Eye
Phase 4
Completed
- Conditions
- Dry Eye SyndromesSjogren's SyndromeDry Eye
- Interventions
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Center for Ophthalmic and Vision Research, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT04835623
- Locations
- 🇺🇸
Center for Ophthalmic and Vision Recearch, Manhattan, New York, United States
© Copyright 2025. All Rights Reserved by MedPath